[Therapy and healthcare applications in the treatment of adult attention deficit hyperactivity disorder: a review].

IF 1.1 4区医学 Q4 CLINICAL NEUROLOGY

Nervenarzt Pub Date : 2025-09-01 Epub Date: 2025-08-04 DOI:10.1007/s00115-025-01855-1

Marie-Christin Atzor, Luisa Jung, Benjamin Selaskowski, Max Pensel, Silke Lux, Alexandra Philipsen, Niclas Braun, Matthias Guth

{"title":"[Therapy and healthcare applications in the treatment of adult attention deficit hyperactivity disorder: a review].","authors":"Marie-Christin Atzor, Luisa Jung, Benjamin Selaskowski, Max Pensel, Silke Lux, Alexandra Philipsen, Niclas Braun, Matthias Guth","doi":"10.1007/s00115-025-01855-1","DOIUrl":null,"url":null,"abstract":"Background: Digital interventions for day-to-day use in adult attention deficit hyperactivity disorder (ADHD) can be a useful further treatment option in addition to established ADHD treatments.Objective: This review of the literature presents the digital interventions for adults with ADHD in Germany that are currently available or in advanced development.Material and methods: The aim is the identification and characterization of the digital interventions available for adult ADHD with a special focus on key features, modes of use, evidence achieved so far and maturity levels.Results: In total, six applications for adults with ADHD (attexis, AwareMe App, AwareMe Chatbot, hiFoon, NeuroNation MED, ORIKO) were identified. Clinical studies with initial proof of efficacy have already been carried out for some of the interventions, for the remainder clinical studies are planned or are currently being carried out.Conclusion: One of the digital interventions is already available on prescription in Germany as so-called digital healthcare apps (digitale Gesundheitsanwendungen, DiGA). Other developers plan to seek regulatory approval in the near future. Innovation potential is seen particularly in the translation of existing applications into new languages and in the future integration of mobile sensing functions.","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"451-457"},"PeriodicalIF":1.1000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411583/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nervenarzt","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00115-025-01855-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/4 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Digital interventions for day-to-day use in adult attention deficit hyperactivity disorder (ADHD) can be a useful further treatment option in addition to established ADHD treatments.

Objective: This review of the literature presents the digital interventions for adults with ADHD in Germany that are currently available or in advanced development.

Material and methods: The aim is the identification and characterization of the digital interventions available for adult ADHD with a special focus on key features, modes of use, evidence achieved so far and maturity levels.

Results: In total, six applications for adults with ADHD (attexis, AwareMe App, AwareMe Chatbot, hiFoon, NeuroNation MED, ORIKO) were identified. Clinical studies with initial proof of efficacy have already been carried out for some of the interventions, for the remainder clinical studies are planned or are currently being carried out.

Conclusion: One of the digital interventions is already available on prescription in Germany as so-called digital healthcare apps (digitale Gesundheitsanwendungen, DiGA). Other developers plan to seek regulatory approval in the near future. Innovation potential is seen particularly in the translation of existing applications into new languages and in the future integration of mobile sensing functions.

Abstract Image

查看原文本刊更多论文

成人注意缺陷多动障碍的治疗与保健应用综述

背景：成人注意缺陷多动障碍（ADHD）日常使用的数字干预可以是除了现有的ADHD治疗方法之外的有用的进一步治疗选择。目的：这篇文献综述介绍了德国目前可用的或处于开发后期的成人ADHD的数字干预措施。材料和方法：目的是识别和描述可用于成人ADHD的数字干预措施，特别关注关键特征、使用模式、迄今为止取得的证据和成熟度水平。结果：共鉴定出6款成人ADHD应用（attexis、AwareMe App、AwareMe Chatbot、hiFoon、NeuroNation MED、ORIKO）。已经对一些干预措施进行了初步疗效证明的临床研究，对其余干预措施正在计划或目前正在进行临床研究。结论：一种数字干预措施已经在德国的处方上可用，即所谓的数字医疗保健应用程序（digitale Gesundheitsanwendungen, DiGA）。其他开发商计划在不久的将来寻求监管部门的批准。创新潜力尤其体现在将现有应用程序翻译成新语言和未来整合移动传感功能方面。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nervenarzt 医学-精神病学

CiteScore

2.50

自引率

18.20%

发文量

169

审稿时长

4-8 weeks

期刊介绍： Der Nervenarzt is an internationally recognized journal addressing neurologists and psychiatrists working in clinical or practical environments. Essential findings and current information from neurology, psychiatry as well as neuropathology, neurosurgery up to psychotherapy are presented. Review articles provide an overview on selected topics and offer the reader a summary of current findings from all fields of neurology and psychiatry. Freely submitted original papers allow the presentation of important clinical studies and serve the scientific exchange. Review articles under the rubric ''Continuing Medical Education'' present verified results of scientific research and their integration into daily practice.